An immunohistochemical study of the diagnostic value of TREM-1 as marker for fatal sepsis cases

References

• Aksaray S, Alagoz P, Inan A, Cevan S, Ozgultekin A. 2016. Diagnostic value of sTREM-1 and procalcitonin levels in the early diagnosis of sepsis. North Clin Istanb. 3:175–182.
   PubMed Web of Science ®Google Scholar
• Arízaga-Ballesteros V, Alcorta-Garcíaa MR, Lázaro-Martínez LC, Amézquita-Gómez JM, Alanís-Cajero JM, Villela L, Castorena-Torres F, Lara-Díaz VJ. 2015. Can s-TREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study. Int J Infect Dis. 30:27–32.
   PubMed Web of Science ®Google Scholar
• Barbatzas C, Pimentel M. 2011. Serum s-TREM-1 as a surrogate marker of treatment outcome in patients with peptic ulcer disease. Dig Dis Sci. 56:3590–3595.
   PubMed Web of Science ®Google Scholar
• Barraud D, Gibot S. 2011. Triggering receptor expressed on myeloid cell-1. Crit Care Clin. 27:265–279.
   PubMed Web of Science ®Google Scholar
• Bellos I, Fitrou G, Daskalakis G, Thomakos N, Papantoniou N, Pergialiotis V. 2018. Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis. Inflam Res. 67:571–578.
   PubMed Web of Science ®Google Scholar
• Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL. 2003. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol. 170:3812–3818.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Dietrich J, Colonna M. 2000. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 164:4991–4995.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Facchetti F, Weigand MA, Colonna M. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 410:1103–1107.
   PubMed Web of Science ®Google Scholar
• Brenner T, Uhle F, Fleming T. 2016. Soluble TREM-1 as a diagnostic and prognostic biomarker in patients with septic shock─an observational clinical study. Biomarkers. 20:1–23.
   Google Scholar
• Carsin H, Assicot M, Feger F, Roy O, Pennacino I, Le Bever H, Ainaud P, Bohuon C. 1997. Evolution and significance of circulating procalcitonins levels compared with IL-6, TNFa and endotoxin levels early after thermal injury. Burns. 23:218–224.
   PubMed Web of Science ®Google Scholar
• Fischer AH, Jacobson KA, Rose J, Zeller R. 2008. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. doi:10.1101/pdb.prot4986
   Google Scholar
• Galassi A, Turatello L, De Salvia A, Neri M, Turillazzi E, La Russa R, Viola RV, Frati P, Fineschi V. 2018. Septic cardiomyopathy: the value of lactoferrin and CD15 as specific markers to corroborate a definitive diagnosis. Int J Immunopathol Pharmacol. 32:2058738418776526.
   Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Zakynthinos S, Baziaka F, Papadomichelakis E, Virtzili S, Koutoukas P, Armaganidis A, Giamarellou H, Roussos C. 2006. Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis. Intens Care Med. 32:237–243.
   PubMed Web of Science ®Google Scholar
• Gibot S, Cravoisy A, Dupays R, Gibot S, Cravoisy A, Dupays R. 2007. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis. 36:604–608.
   Google Scholar
• Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B. 2005. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 33:792–796.
   PubMed Web of Science ®Google Scholar
• Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE. 2004. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Int Med. 141:9–15.
   PubMed Web of Science ®Google Scholar
• Gibot S, Massin F, Alauzet C, Montemont C, Lozniewski A, Bollaert PE, Levy B. 2008. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med. 36:504–510.
   PubMed Web of Science ®Google Scholar
• Herwig MC, Tsokos M, Hermanns MI, Kirkpatrick CJ, Müller AM. 2013. Vascular endothelial Cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures. Pathobiology. 80:245–251.
   PubMed Web of Science ®Google Scholar
• Latour-Pérez J, Alcalá-López A, García-García MA, Sánchez-Hernández JF, Abad-Terrado C, Viedma-Contreras JA, Masiá-Canuto M, Broch-Porcar MJ, Arizo-León D, González-Tejera M, Bonilla-Rovira F, Gutiérrez F. 2010. Prognostic value of the s-TREM-1 plasma values in patients with sepsis: a cohort study. Clin Biochem. 43:720–724.
   PubMed Web of Science ®Google Scholar
• Maiese A, Del Nonno F, Dell’Aquila M, Moauro M, Baiocchini A, Mastracchio A, Bolino G. 2017. Postmortem diagnosis of sepsis: a preliminary immunohistochemical study with an anti-procalcitonin antibody. Leg Med (Tokyo). 28:1–5.
   PubMed Web of Science ®Google Scholar
• Müller AM, Gruhn KM, Herwig MC, Tsokos M. 2008. VE-cadherin and ACE: markers for sepsis in post mortem examination? Leg Med. 10:257–263.
   PubMedGoogle Scholar
• Oku R, Oda S, Nakada TA, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Tateishi Y, Ito M, Iseki T, Hirasawa H. 2013. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine. 61:112–117.
   PubMed Web of Science ®Google Scholar
• Palmiere C, Bardy D, Mangin P, Augsburger M. 2013. Value of s-TREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis. J Infect. 67:545–555.
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez FA, Minei JP. 2009. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit. Surg Infect. 10:435–439.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. 2016. The third international consensus definitions for sepsis and septic shock (sepsis-3). J Am Med Assoc. 315:801–810.
   PubMed Web of Science ®Google Scholar
• Tsokos M. 2007. Postmortem diagnosis of sepsis. For Sci Int. 165:155–164.
   Google Scholar
• Wang H, Chen B. 2011. Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis. World J Emerg Med. 2:190–194.
   PubMedGoogle Scholar
• Weiss G, Lai C, Fife ME, Grabiec AM, Tildy B, Snelgrove RJ, Xin G, Lloyd CM, Hussell T. 2017. Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors. Mucosal Immunol. 10:1021–1030.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang F, Fan X, Bao R, Bo L, Li J, Deng X. 2012. Accuracy of plasma s-TREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care. 16:R229.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Takahiro N, Kamei K, Ku Y, Kuroda Y. 2008. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med. 36:2048–2053.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Mehta HJ, Mohammed K, Nasreen N, Roman R, Brantly M, Sadikot RT. 2014. TREM-1 is induced in tumor associated macrophages by cyclo-oxygenase pathway in human non-small cell lung cancer. PLoS One. 19:e94241.
   Google Scholar
• Yuan Z, Syed MA, Panchal D, Yuan Z, Syed MA, Panchal D, Rogers D, Joo M, Sadikot RT. 2012. Curcumin mediated epigenetic modulation inhibits TREM-1 expression in response to lipopolysaccharide. Int J Biochem Cell Biol. 44:2032–2043.
   PubMed Web of Science ®Google Scholar